Clinical Trial

Butorphanol for Pain Relief After Cesarean Section: A Retrospective Study

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 16, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study explored the association between postoperative functional recovery and the formula of analgesic pumps as well as other related factors (such as age, intraoperative blood loss, operation duration, etc.) by retrospectively analyzing the clinical data of patients undergoing cesarean section in the main campus and branches of Sichuan Provincial People's Hospital from September 2024 to June 2025. The value of this study lies in: 1) providing a basis for optimizing the postoperative analgesia plan after cesarean section. 2) To provide references for the formulation of personalized analgesia strategies in clinical practice, improve the postoperative recovery quality of patients, promote the concept of enhanced recovery after surgery, and reduce the medical burden.
Trial Details
NCT Number NCT07175363
Lead Sponsor Sichuan Provincial People's Hospital
Conditions Caesarean Section
Enrollment 2,500 participants
Start Date 2025-09-20
Primary Completion 2025-09-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-16